These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 7763308

  • 21. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics.
    Hermans JJ, Thijssen HH.
    Br J Pharmacol; 1993 Sep; 110(1):482-90. PubMed ID: 8220911
    [Abstract] [Full Text] [Related]

  • 22. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ, Smith TJ, Friesen MJ, Tynes RE, Yang CS, Murphy SE.
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [Abstract] [Full Text] [Related]

  • 23. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase.
    Crespi CL, Miller VP.
    Pharmacogenetics; 1997 Jun; 7(3):203-10. PubMed ID: 9241660
    [Abstract] [Full Text] [Related]

  • 24. Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes.
    Nomura A, Sakurai E, Hikichi N.
    J Pharm Pharmacol; 1997 Mar; 49(3):257-62. PubMed ID: 9231341
    [Abstract] [Full Text] [Related]

  • 25. Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation.
    Hosoi Y, Uno Y, Murayama N, Fujino H, Shukuya M, Iwasaki K, Shimizu M, Utoh M, Yamazaki H.
    Biochem Pharmacol; 2012 Dec 15; 84(12):1691-5. PubMed ID: 23041648
    [Abstract] [Full Text] [Related]

  • 26. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil.
    Tracy TS, Korzekwa KR, Gonzalez FJ, Wainer IW.
    Br J Clin Pharmacol; 1999 May 15; 47(5):545-52. PubMed ID: 10336579
    [Abstract] [Full Text] [Related]

  • 27. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
    Murray M.
    Mol Pharmacol; 1992 Nov 15; 42(5):931-8. PubMed ID: 1435757
    [Abstract] [Full Text] [Related]

  • 28. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.
    Rettie AE, Korzekwa KR, Kunze KL, Lawrence RF, Eddy AC, Aoyama T, Gelboin HV, Gonzalez FJ, Trager WF.
    Chem Res Toxicol; 1992 Nov 15; 5(1):54-9. PubMed ID: 1581537
    [Abstract] [Full Text] [Related]

  • 29. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.
    Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y.
    Drug Metab Dispos; 1998 Mar 15; 26(3):261-6. PubMed ID: 9492390
    [Abstract] [Full Text] [Related]

  • 30. Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model.
    Hutzler JM, Hauer MJ, Tracy TS.
    Drug Metab Dispos; 2001 Jul 15; 29(7):1029-34. PubMed ID: 11408370
    [Abstract] [Full Text] [Related]

  • 31. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
    Komatsu T, Yamazaki H, Shimada N, Nakajima M, Yokoi T.
    Drug Metab Dispos; 2000 Dec 15; 28(12):1457-63. PubMed ID: 11095583
    [Abstract] [Full Text] [Related]

  • 32. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers.
    Yamazaki H, Shimada T.
    Biochem Pharmacol; 1997 Dec 01; 54(11):1195-203. PubMed ID: 9416970
    [Abstract] [Full Text] [Related]

  • 33. Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.
    Veronese ME, Doecke CJ, Mackenzie PI, McManus ME, Miners JO, Rees DL, Gasser R, Meyer UA, Birkett DJ.
    Biochem J; 1993 Jan 15; 289 ( Pt 2)(Pt 2):533-8. PubMed ID: 8424795
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
    Shen S, Marchick MR, Davis MR, Doss GA, Pohl LR.
    Chem Res Toxicol; 1999 Feb 15; 12(2):214-22. PubMed ID: 10027801
    [Abstract] [Full Text] [Related]

  • 39. Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach.
    Venkatakrishnan K, von Moltke LL, Greenblatt DJ.
    J Pharm Sci; 1998 Jul 15; 87(7):845-53. PubMed ID: 9649353
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.